RM Califf, EJ Topol, BS George, JM Boswick, … - The American Journal of Medicine, 1988 - Elsevier : Quantitation of blood loss during the patients' hospital stay included a
median drop in hematocrit of 11.4 points, a median nadir hematocrit of 31.2, a
14 percent rate of significant clinically evident bleeding, and a 31 ... Cited by 84 - Related articles - All 4 versions
- ►ahajournals.org [PDF] CW Francis, DG Connaghan, WL Scott, VJ … - Circulation, 1987 - Am Heart Assoc THROMBOSIS is a pivotal event in the pathogenesis ofmyocardial infarction, with
a 70% to 90% incidence of acute thrombotic occlusion of the artery supplying the
infarcted zone in patients with transmural infarc- tions.' In addition, the ... Cited by 66 - Related articles - All 4 versions
CS Kase, MS Pessin, JA Zivin, GJ del Zoppo, … - The American journal of medicine, 1992 - Elsevier : Among 1,700 patients with an acute MI treated with an investigational
two-chain rtPA, duteplase (Burroughs Wellcome Co., Research Triangle Park, NC),
nine (0.53%) developed symptomatic ICH. Neurologic symptoms occurred ... Cited by 63 - Related articles - All 5 versions
RA Graor, B Risius, FV Lucas, JR Young, WF … - Circulation, 1986 - ncbi.nlm.nih.gov Thirty-three patients with thrombosed peripheral arteries and bypass grafts, as
confirmed by angiography, were treated with recombinant human tissue-type
plasminogen activator (rt-PA). Twenty-six patients were treated with a dose ... Cited by 59 - Related articles - All 4 versions
SM Papadopoulos, WF Chandler, MS Salamat, … - Journal of neurosurgery, 1987 - thejns.org The authors designed a study to evaluate the effect of intravenous TPA
administered 2 hours after acute thromboembolic stroke in rats. This time course
was chosen to simulate an analogous clinical situation. Middle cerebral ... Cited by 59 - Related articles - All 4 versions
- ►nih.gov [PDF] JI Weitz, B Leslie, J Ginsberg - Journal of Clinical Investigation, 1991 - pubmedcentral.nih.gov Despite its affinity for fibrin, tissue plasminogen activator(t- PA)
administration causes systemic fibrinogenolysis. To inves- tigate the mechanism,
t-PA was incubated with plasma in the presence or absence of a fibrin clot, ... Cited by 45 - Related articles - All 6 versions
- ►ahajournals.org [PDF] DC Stump, RM Califf, EJ Topol, K Sigmon, D … - Circulation, 1989 - Am Heart Assoc David C. Stump, MD, Robert M. Califf, MD, Eric J. Topol, MD, Kristina Sigmon,
MA, ... Dagnija Thornton, BS, Ramona Masek, RN, Linda Anderson, RN, ... Desire
Collen, MD, PhD, and the TAMI Study Group ... Coagulation analysis was ... Cited by 46 - Related articles - All 6 versions
- ►nih.gov [PDF] JI Weitz, MK Cruickshank, B Thong, B Leslie, … - Journal of Clinical Investigation, 1988 - pubmedcentral.nih.gov In five patients with venous thromboembolic disease treated with recombinant
tissue-type plasminogen activator (rt-PA), there was a marked increase in the
mean concentrations of fibrinopeptide A (from 0.6 to 5.9 nM; P < 0.0001) ... Cited by 43 - Related articles - All 4 versions
SE Carlson, MS Aldrich, HS Greenberg, EJ … - Archives of Neurology, 1988 - archneur.highwire.org \s=b\ Tissue plasminogen activator's thrombolytic action is relatively specific
for fibrin; however, systemic bleeding can occur in patients, especially when
heparin is simultaneously administered. We de- scribe two cases of ... Cited by 41 - Related articles - All 4 versions
JC Blankenship, M Indeck - The American journal of medicine, 1993 - Elsevier 7.L Norgren, B Eklof, JE Gjores, A Lohe and W Staszkiewicz, Spontan ruptur av
lever och mjälte vid streptokinasbehandling av djup ventrombos, Lakartidningen
75 (1978), pp. 777–778. ... 11.A ladicicco, R Manfrini, S Tabilio and CA ... Cited by 33 - Related articles - BL Direct - All 4 versions
